MC1337A1 - Interferon de fibroblastes humains sous la forme d'une proteine homogene et sa preparation - Google Patents

Interferon de fibroblastes humains sous la forme d'une proteine homogene et sa preparation

Info

Publication number
MC1337A1
MC1337A1 MC801460A MC1460A MC1337A1 MC 1337 A1 MC1337 A1 MC 1337A1 MC 801460 A MC801460 A MC 801460A MC 1460 A MC1460 A MC 1460A MC 1337 A1 MC1337 A1 MC 1337A1
Authority
MC
Monaco
Prior art keywords
interferon
preparation
human fibroblasts
homogeneous protein
homogeneous
Prior art date
Application number
MC801460A
Other languages
English (en)
French (fr)
Inventor
S Pestka
H Friesen
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1337A1 publication Critical patent/MC1337A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/565IFN-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MC801460A 1979-07-31 1980-07-29 Interferon de fibroblastes humains sous la forme d'une proteine homogene et sa preparation MC1337A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6237179A 1979-07-31 1979-07-31
US13063580A 1980-03-14 1980-03-14

Publications (1)

Publication Number Publication Date
MC1337A1 true MC1337A1 (fr) 1981-04-21

Family

ID=26742182

Family Applications (1)

Application Number Title Priority Date Filing Date
MC801460A MC1337A1 (fr) 1979-07-31 1980-07-29 Interferon de fibroblastes humains sous la forme d'une proteine homogene et sa preparation

Country Status (33)

Country Link
US (1) US5015730A (fi)
JP (1) JPH02138226A (fi)
AR (1) AR229931A1 (fi)
AT (1) AT372387B (fi)
AU (1) AU536274B2 (fi)
CA (1) CA1146468A (fi)
CH (1) CH648331A5 (fi)
DE (1) DE3028919A1 (fi)
DK (1) DK159825C (fi)
DO (1) DOP1980002948A (fi)
ES (1) ES8200560A1 (fi)
FI (1) FI70721C (fi)
FR (1) FR2462167B1 (fi)
GB (1) GB2055384B (fi)
HK (1) HK40384A (fi)
HU (1) HU185382B (fi)
IE (1) IE50075B1 (fi)
IL (1) IL60697A (fi)
IT (1) IT1132269B (fi)
KE (1) KE3364A (fi)
LU (1) LU82673A1 (fi)
MC (1) MC1337A1 (fi)
MY (1) MY8500274A (fi)
NL (1) NL8004361A (fi)
NO (1) NO151158C (fi)
NZ (1) NZ194495A (fi)
PH (2) PH17738A (fi)
PT (1) PT71625B (fi)
RO (1) RO81474B (fi)
SE (1) SE466290B (fi)
YU (1) YU193480A (fi)
ZA (1) ZA803943B (fi)
ZW (1) ZW17980A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2687995B2 (ja) 1980-04-03 1997-12-08 バイオゲン インコーポレイテッド Dna配列、組替えdna分子およびヒト繊維芽細胞インターフェロン様ポリペプチドの製造方法
IT1139487B (it) * 1980-09-25 1986-09-24 Genentech Inc Produzione microbica di interferone di fibroblasti umani
ZA83768B (en) * 1982-03-01 1983-10-26 Hoffmann La Roche Homogeneous human immune interferon and process therefor
US4966843A (en) * 1982-11-01 1990-10-30 Cetus Corporation Expression of interferon genes in Chinese hamster ovary cells
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
US4894330A (en) * 1986-12-23 1990-01-16 Cetus Corporation Purification of recombinant beta-interferon incorporating RP-HPLC
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US20050002902A1 (en) * 1995-12-28 2005-01-06 Liming Yu Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
ES2664924T3 (es) 2005-08-26 2018-04-24 Ares Trading S.A. Procedimiento para la preparación del interferón beta glicosilado
AU2006323925B2 (en) 2005-12-09 2012-08-02 Ares Trading S.A. Method for purifying FSH or a FSH mutant
JP2011500756A (ja) * 2007-10-22 2011-01-06 メルク セローノ ソシエテ アノニム Fc融合タンパク質を精製する方法
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta

Also Published As

Publication number Publication date
NO802297L (no) 1981-02-02
ZW17980A1 (en) 1981-03-18
IL60697A0 (en) 1980-09-16
ES493849A0 (es) 1981-11-16
DK328880A (da) 1981-02-01
US5015730A (en) 1991-05-14
DE3028919C2 (fi) 1988-02-18
FI70721C (fi) 1986-10-06
CH648331A5 (de) 1985-03-15
DE3028919A1 (de) 1981-02-19
NO151158C (no) 1985-02-20
SE8005498L (sv) 1981-02-01
FI70721B (fi) 1986-06-26
RO81474B (ro) 1983-04-30
LU82673A1 (fr) 1982-02-17
HU185382B (en) 1985-01-28
HK40384A (en) 1984-05-18
GB2055384B (en) 1983-08-10
PT71625A (en) 1980-08-01
IE50075B1 (en) 1986-02-05
AT372387B (de) 1983-09-26
NL8004361A (nl) 1981-02-03
PT71625B (en) 1981-12-17
AU6091480A (en) 1981-02-05
AU536274B2 (en) 1984-05-03
DOP1980002948A (es) 1989-04-20
RO81474A (ro) 1983-04-29
PH17738A (en) 1984-11-23
IT1132269B (it) 1986-07-02
KE3364A (en) 1984-02-03
FI802400A (fi) 1981-02-01
IL60697A (en) 1984-04-30
GB2055384A (en) 1981-03-04
YU193480A (en) 1984-04-30
AR229931A1 (es) 1984-01-31
NZ194495A (en) 1984-07-31
PH18479A (en) 1985-07-18
DK159825B (da) 1990-12-10
CA1146468A (en) 1983-05-17
DK159825C (da) 1991-04-29
NO151158B (no) 1984-11-12
FR2462167A1 (fr) 1981-02-13
IT8023801A0 (it) 1980-07-30
IE801589L (en) 1981-01-31
MY8500274A (en) 1985-12-31
ZA803943B (en) 1981-06-24
JPH02138226A (ja) 1990-05-28
FR2462167B1 (fr) 1985-07-05
ATA395080A (de) 1983-02-15
ES8200560A1 (es) 1981-11-16
SE466290B (sv) 1992-01-27

Similar Documents

Publication Publication Date Title
FR2440959B2 (fr) Polyesterlactides et leur application dans la fabrication d'articles chirurgicaux
AR241097A1 (es) "producto de conservacion de la madera"
MC1337A1 (fr) Interferon de fibroblastes humains sous la forme d'une proteine homogene et sa preparation
IT1230485B (it) Particelle fini di poliorganosilsesquiossano e procedimento per produrre le stesse
IT8768027A0 (it) Derivati di 1 piperazinil pirimidina loro preparazione e impiego in terapia e cosmesi
GB2107587B (en) Composition in the form of a shampoo based on anthralin or a derivative thereof and its use in the treatment of skin diseases
DK87485A (da) Modificeret hvede ''b''-stivelses klaebemiddel til brug ved fremstillingaf boelgepap
FR2609391B1 (fr) Preparations pharmaceutiques sous forme de suppositoires bioadhesifs
HU9500841D0 (en) Interferon regulatory factors 1 and 2 in the diagnosis of tumorogenicity
FI894546A (fi) Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi
MX9260A (es) Procedimiento de preparacion de nuevos derivados de 1-bencenosulfonil-2-oxo-5-alcoxipirrolidina y producto obtenido
ES546931A0 (es) Metodo de elaborar braguetas de pantalon y similares
ES263191Y (es) "disposicion perfeccionada de fijacion de dientes en excavadoras y-o similares".
EG18920A (en) N - benzoyl - n'- 2,5 dihalo - 4 - perefluoroalko-xyphenylureas, their preparation and use in the control of pests
KR890701004A (ko) 개선된 생리효과를 가지는 식물의 제조 및 이 식물의 용도
EP0437026A3 (en) Use of tandospirone in the treatment of depression
ZA834344B (en) Use of 1,4-dihydropyridines in antiarteriosclerotic agents and their preparation
GB2201171B (en) Compositions for use in the treatment of cellulosic materials and their preparation
ATE142503T1 (de) Arzneimittelzubereitung bei der behandlung von tonsillitis
FR2542744B2 (fr) 3',5'-diarabinosides, leur preparation et leur application en therapeutique
GB9008215D0 (en) Improvements in or relating to the treatment of surfaces
AU641157B2 (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma
NZ234102A (en) Preparation of alpha-alkoxyacetic acids and their salts
NZ221570A (en) 3-alkyl-4-heptenoic or -heptanoic acids and use as intermediates in the preparation of n-(s-3-alkylheptanoyl)-d-gamma-glutamyl-glycyl-d-alanine
FR2548668B1 (fr) Derives d'hexahydro-indolo-naphtyridines, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
YP Annual fee paid